Influence
March 31, 2022

Regenstrief researcher will be part of life sciences expert panel

Regenstrief researcher will be part of life sciences expert panel

Regenstrief Research Scientist NiCole Keith, PhD, will join other Central Indiana life sciences leaders to discuss Indiana’s life-sciences industry.

The panel will elaborate on the pandemic’s effect on research and product development, federal policies and industry trends, and venture capital investments in Indiana companies, among other subjects. In addition to Dr. Keith, featured panelists are Kent Hawryluk, MBX Biosciences, Inc.; Marcela A. Kirberger, Elanco Animal Health, Inc.; Theresa S. Mayer, Purdue University; and Brandy Matthews, Eli Lilly and Company. The discussion will be moderated by Indianapolis Business Journal reporter John Russell.

Dr. Keith is a physical activity researcher specializing in community-based participatory research with a focus on health equity. She co-created the Physically Active Residential Communities and Schools (PARCS) program — a partnership among Indianapolis Public Schools, Eskenazi Health Federally Qualified Health Centers and IUPUI. This award-winning program provides exercise opportunities for more than 3,000 adults and children living in Indianapolis inner-city communities. She also helped to write the State of Aging in Indiana report.

In addition to her role as a research scientist at Regenstrief, Dr. Keith is the associate dean of faculty affairs and a professor at Indiana University School of Health & Human Sciences. Dr. Keith was the 2020-2021 president of the American College of Sports Medicine, an Indianapolis-based organization of more than 55,000 members.

The expert panel will be featured as part of the IBJ Power Breakfast Series.

register here

Related News

National study confirms breakthrough COVID cases are less severe than COVID in unvaccinated adults

National study confirms breakthrough COVID cases are less severe than COVID in unvaccinated adults

Hospitalizations, ICU admissions, and hospital deaths lower for those who are vaccinated and boosted Individuals who, despite having been

April Savoy, PhD

Redesigning diabetes technology to detect low blood sugar in older adults with diabetes and Alzheimer’s disease

Regenstrief Institute Research Scientist April Savoy, PhD, a human factors engineer and health services researcher, is developing and testing

illustration of digestive tract with magnifier and stool sample container

New study provides evidence for three-year interval for multi-target stool DNA screening for those at average risk of colon cancer

A scientific study exploring the appropriate interval for colorectal cancer screening via non-invasive multi-target stool DNA testing for individuals

Dr. Tom Imperiale on tailoring colonoscopy screening for 45- to 49-year-olds

Dr. Tom Imperiale on tailoring colonoscopy screening for 45- to 49-year-olds

Dr. Tom Imperiale explains why physicians should be good stewards of colonoscopy resources.  [button_links href=”https://www.regenstrief.org/article/regenstrief-researcher-calls-for-tailoring-colorectal-cancer-screening-45-49-year-olds/” title=”Read the full